ACTIVE IMMUNIZATION OF METASTATIC MELANOMA PATIENTS WITH INTERLEUKIN-4 TRANSDUCED, ALLOGENEIC MELANOMA-CELLS - A PHASE I-II STUDY

被引：31

作者：

CASCINELLI, N

FOA, R

PARMIANI, G

ARIENTI, F

BELLI, F

BERNENGO, MG

CLEMENTE, C

COLOMBO, MP

GUARINI, A

ILLENI, MT

MASCHERONI, L

MELANI, C

PRADA, A

SULESUSO, J

机构：

[1] UNIV TURIN,DIPARTIMENTO SCI BIOMED & ONCOL UMANA,I-10124 TURIN,ITALY

[2] UNIV TURIN,DERMATOL CLIN,I-10124 TURIN,ITALY

来源：

HUMAN GENE THERAPY | 1994年 / 5卷 / 08期

关键词：

D O I：

10.1089/hum.1994.5.8-1059

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

[No abstract available]

引用

页码：1059 / 1064

页数：6

共 42 条

[1] MELANOMA-CELLS AND NORMAL MELANOCYTES SHARE ANTIGENS RECOGNIZED BY HLA-A2-RESTRICTED CYTOTOXIC T-CELL CLONES FROM MELANOMA PATIENTS [J].

ANICHINI, A ;

MACCALLI, C ;

MORTARINI, R ;

SALVI, S ;

MAZZOCCHI, A ;

SQUARCINA, P ;

HERLYN, M ;

PARMIANI, G .

JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (04) :989-998

[2] ADOPTIVE IMMUNOTHERAPY OF ADVANCED MELANOMA PATIENTS WITH INTERLEUKIN-2 (IL-2) AND TUMOR-INFILTRATING LYMPHOCYTES SELECTED INVITRO WITH LOW-DOSES OF IL-2 [J].

ARIENTI, F ;

BELLI, F ;

RIVOLTINI, L ;

GAMBACORTIPASSERINI, C ;

FURLAN, L ;

MASCHERONI, L ;

PRADA, A ;

RIZZI, M ;

MARCHESI, E ;

VAGLINI, M ;

PARMIANI, G ;

CASCINELLI, N .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 1993, 36 (05) :315-322

[3] PHASE-I EVALUATION OF THRICE-DAILY INTRAVENOUS BOLUS INTERLEUKIN-4 IN PATIENTS WITH REFRACTORY MALIGNANCY [J].

ATKINS, MB ;

VACHINO, G ;

TILG, HJ ;

KARP, DD ;

ROBERT, NJ ;

KAPPLER, K ;

MIER, JW .

JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (11) :1802-1809

[4] CYTOKINES AND CANCER - EXPERIMENTAL SYSTEMS [J].

BLANKENSTEIN, T ;

ROWLEY, DA ;

SCHREIBER, H .

CURRENT OPINION IN IMMUNOLOGY, 1991, 3 (05) :694-698

[5]

BOSCO M, 1990, J IMMUNOL, V145, P3136

[6] THE TYROSINASE GENE CODES FOR AN ANTIGEN RECOGNIZED BY AUTOLOGOUS CYTOLYTIC T-LYMPHOCYTES ON HLA-A2 MELANOMAS [J].

BRICHARD, V ;

VANPEL, A ;

WOLFEL, T ;

WOLFEL, C ;

DEPLAEN, E ;

LETHE, B ;

COULIE, P ;

BOON, T .

JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (02) :489-495

[7]

COLOMBO MP, 1992, CANCER RES, V52, P4853

[8] CYTOKINE GENE-TRANSFER IN TUMOR-INHIBITION AND TUMOR-THERAPY - WHERE ARE WE NOW [J].

COLOMBO, MP ;

FORNI, G .

IMMUNOLOGY TODAY, 1994, 15 (02) :48-51

[9] VACCINATION WITH IRRADIATED TUMOR-CELLS ENGINEERED TO SECRETE MURINE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR STIMULATES POTENT, SPECIFIC, AND LONG-LASTING ANTITUMOR IMMUNITY [J].

DRANOFF, G ;

JAFFEE, E ;

LAZENBY, A ;

GOLUMBEK, P ;

LEVITSKY, H ;

BROSE, K ;

JACKSON, V ;

HAMADA, H ;

PARDOLL, D ;

MULLIGAN, RC .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (08) :3539-3543

[10] INTERLEUKIN-2 PRODUCTION BY TUMOR-CELLS BYPASSES T-HELPER FUNCTION IN THE GENERATION OF AN ANTITUMOR RESPONSE [J].

FEARON, ER ;

PARDOLL, DM ;

ITAYA, T ;

GOLUMBEK, P ;

LEVITSKY, HI ;

SIMONS, JW ;

KARASUYAMA, H ;

VOGELSTEIN, B ;

FROST, P .

CELL, 1990, 60 (03) :397-403

← 1 2 3 4 5 →